Fragrance avoidance
Nothing to weigh for this context yet.
We have no published hazard signal for this ingredient, so we cannot say how it behaves in this context — that is missing evidence, not a clean result.
- beauty
- pharma
RH-OLIGOPEPTIDE-1
Concern score
Not assessed — no hazard data yet.
RH-OLIGOPEPTIDE-1 in plain language
Used in cosmetics as a skin-conditioning agent.
- Skin conditioning
- We haven't assessed a concern score for this ingredient yet. It is listed for cosmetic use in the EU.
Regulation
No restrictions found. RH-OLIGOPEPTIDE-1 appears in these published regulatory listings.
- In marketed US drugs
EUCosIngActiverh-Oligopeptide-1 is a single chain recombinant human peptide, produced by fermentation in E. coli or Pichia pastoris and contains 53 amino acids. The starting gene is directly isolated from a human cell which codes for Epidermal Growth Factor, and codes for a total of 1207 amino acids which may contain disulfide bonds and/or sugar. The protein consists of the proper sequence of standard amino acids. EGF; Epidermal Growth Factor Restriction: II/416
- rh-Oligopeptide-1 is a single chain recombinant human peptide, produced by fermentation in E. coli or Pichia pastoris and contains 53 amino acids. The starting gene is directly isolated from a human cell which codes for Epidermal Growth Factor, and codes for a total of 1207 amino acids which may contain disulfide bonds and/or sugar. The protein consists of the proper sequence of standard amino acids. EGF; Epidermal Growth Factor Restriction: II/416Source →
USFDAmarketed drug occurrenceFDA NDC lists this ingredient in 2 active drug products and 2 total products.
- FDA NDC lists this ingredient in 2 active drug products and 2 total products.Source →
Expert safety opinions
No expert opinion on file for RH-OLIGOPEPTIDE-1. These are the independent scientific bodies that assess ingredients like this one; we show an opinion only when a record we hold cites it.
SCCS
EU Scientific Committee on Consumer Safety
No SCCS opinion on file.
CIR
Cosmetic Ingredient Review (US expert panel)
No CIR safety assessment on file.
Evidence & sources
No graded research studies for RH-OLIGOPEPTIDE-1 yet. This record is compiled from the published data sources below — registries and regulatory listings, not study findings.
Suitability
Context-specific fit derived from published classifications and the current ingredient evidence profile.
No signal in this context
Where it has been recorded
How often FDA National Drug Code directory has listed RH-OLIGOPEPTIDE-1 in a product composition. These are source records, not Greenveil catalog products.
Source records
2
Typical roles
Skin conditioning